Abstract P3-07-28: SERENA-1: Updated Analyses from a Phase 1 Study of the Next Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Combined with Abemaciclib, in Women with ER-positive, HER2-negative Advanced Breast Cancer Nicholas Turner , Christos Vaklavas , Emiliano Calvo , Javier Garcia-Corbacho , Jason Incorvati , Manuel Ruiz Borrego , Chris Twelves , Anne Armstrong , Begoña Bermejo , Erika Hamilton , Mafalda Oliveira , Eva Ciruelos , Peter Kabos , Manish R Patel , Maria Borrell , Howard Burris , Bruno de Paula , Alejandro Falcon , Cristina Hernando , Irene Moreno , Ciara S. O’Brien , Elena Shagisultanova , Ivan Victoria Ruiz , Judy S. Wang , Mei Wei , Tim Brier , Danielle Carroll , Carmela Ciardullo , Lisa Gibbons , itziar irurzun-Arana , Tony Jack , Bistra Kirova , Teresa Klinowska , Justin Lindemann , Julie Maidment , Alastair Mathewson , Rhiannon Maudsley , Robert McEwen , Christopher Morrow , Andy Sykes , Richard D. Baird Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
